Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antigen-specific, MHC-unrestricted T cells.

O J Finn1

  • 1Department of Molecular Genetics and Biochemistry, University of Pittsburg School of Medicine, PA 15261.

Biotherapy (Dordrecht, Netherlands)
|January 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Immuno-oncology: understanding the function and dysfunction of the immune system in cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2012
Same author

H-2 antigen expression: Loss in vitro, restoration in vivo, and correlation with cell-mediated cytotoxicity in a mouse lymphoma cell line.

Immunogenetics·2011
Same author

T-cell death and cancer immune tolerance.

Cell death and differentiation·2007
Same author

Innate and adaptive immunity in lung cancer.

Novartis Foundation symposium·2007
Same author

Identification of cyclin B1 as a shared human epithelial tumor-associated antigen recognized by T cells.

The Journal of experimental medicine·2001
Same author

Activated granulocytes and granulocyte-derived hydrogen peroxide are the underlying mechanism of suppression of t-cell function in advanced cancer patients.

Cancer research·2001
Same journal

Cytokine effect on ex vivo expansion of haemopoietic stem cells from different human sources.

Biotherapy (Dordrecht, Netherlands)·1999
Same journal

Elevated serum level of thioredoxin in patients with hepatocellular carcinoma.

Biotherapy (Dordrecht, Netherlands)·1999
Same journal

Contribution of cytokines on the suppression of lung metastasis.

Biotherapy (Dordrecht, Netherlands)·1999
Same journal

Antitumor effect of a peptide-glucan preparation extracted from Agaricus blazei in a double-grafted tumor system in mice.

Biotherapy (Dordrecht, Netherlands)·1999
Same journal

Levamisole and interleukin-2 for advanced malignancy.

Biotherapy (Dordrecht, Netherlands)·1999
Same journal

The use of BRM-activated killer cells in adoptive immunotherapy: a pilot study with nine advanced cancer patients.

Biotherapy (Dordrecht, Netherlands)·1999
See all related articles

T cells typically recognize foreign antigens presented by major histocompatibility complex (MHC) molecules. This review explores how T cells can bypass MHC restriction, focusing on direct antigen binding to the T cell receptor (TCR).

Area of Science:

  • Immunology
  • Molecular Biology

Background:

  • T cell recognition of antigens is primarily mediated by the T cell receptor (TCR) interacting with foreign antigens complexed with major histocompatibility complex (MHC) molecules.
  • This interaction typically results in antigen-specific and MHC-restricted effector functions.

Purpose of the Study:

  • To review the mechanisms by which T cells can exhibit MHC-unrestricted recognition.
  • To focus on the less-explored possibility of direct antigen binding to the TCR, bypassing MHC presentation.

Main Methods:

  • Literature review of immunological studies on T cell receptor (TCR) and major histocompatibility complex (MHC) interactions.
  • Analysis of mechanisms underlying MHC-restricted and MHC-unrestricted T cell activation.

Main Results:

Related Experiment Videos

  • T cells normally require antigen presentation by MHC molecules for activation.
  • MHC-unrestricted T cell recognition can occur via an additional MHC-unrestricted receptor (NK-like) or through direct antigen binding to the TCR.
  • Direct antigen binding to the TCR without MHC presentation is a less-described but significant mechanism.

Conclusions:

  • While MHC-restricted antigen recognition is well-established, alternative pathways exist.
  • The direct activation of T cells by antigens binding to the TCR, independent of MHC presentation, warrants further investigation.